Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Controlling the amount of adipose tissue is key to combat obesity

Obesity is seen as the great pandemia of the XXI century. Recent data point to more than a billion adults in the world suffering from overweight, of which 300 million are clinically obese. What is more, the rates of child obesity show a worrying increase, with more than 155 million children and adolescents being overweight, of which 40 million are clearly obese.

29 Dec 2010

NYBC urges communities to donate blood

New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, and New Jersey, calls upon our communities to please donate blood and platelets, after our tally of blood donations lost due to the weather doubled overnight – to more than 2,000.

29 Dec 2010

Top weight-loss behaviors

Losing weight and saving money are the top New Year's resolutions expected to vex Americans this year, experts say.

29 Dec 2010

Fried fish consumption linked to high stroke rates: Study

Researchers from Emory University (Atlanta, Georgia), the University of Alabama (Birmingham, Alabama), and Boston University (Boston, University) have found that omega-3 fatty acids contained in fish has “favourable effects on platelet aggregation, blood pressure, lipid profile, endothelial function, and ischemic stroke risk.” The team led by Dr. Fadi Nahab decided to look into the racial and geographical aspects of preparing and eating fish and its effects.

28 Dec 2010

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.

28 Dec 2010

NYBC calls upon community to donate blood, platelets

New York Blood Center serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania calls upon the community to please donate blood and platelets, as the tri-state area braces for a huge predicted winter snowstorm.

27 Dec 2010

Molecular-level insights into how physical activity influences the heart

Everyone knows that exercise comes with metabolic and cardiovascular benefits, but scientists understand surprisingly little about how physical activity influences the heart itself. Now, a new study in the December 23rd issue of Cell, a Cell Press publication, offers some of the first molecular-level insights.

24 Dec 2010

Scientists tweak gene to mimick heart-strengthening effects of endurance training in sedentary mice

By tweaking a single gene, scientists have mimicked in sedentary mice the heart-strengthening effects of two weeks of endurance training, according to a report from Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center (BIDMC).

24 Dec 2010

Promising initial data from STABLE clinical trial for endovascular treatment of Type B aortic dissection

Study investigators reported positive steps in Cook Medical's efforts to gain FDA approval of the treatment assessed in the STABLE clinical trial, designed to evaluate the safety and efficacy of a proximal endograft and a distal uncovered stent for the endovascular treatment of Type B aortic dissection for purposes of seeking FDA approval. The findings were presented by Dr. Joseph Lombardi at the 37th annual VEITHsymposium.

23 Dec 2010

FDA approves Novartis' Amturnide for treatment of high blood pressure

Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

23 Dec 2010

Top ten advances in cardiovascular, stroke research in 2010

Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research recognized by the American Heart Association/American Stroke Association.

22 Dec 2010

Poison centers raise concern over dangerous substance marketed as bath salts

Doctors and clinicians at U.S. poison centers are increasingly concerned about products marketed as bath salts that are causing increased blood pressure, increased heart rate, agitation, hallucinations, extreme paranoia and delusions.

22 Dec 2010

State Roundup: New Minn. Gov.'s plans to expand Medicaid could be off to slow start; Ariz. Gov. asks for federal help

Minnesota Gov.-elect Mark Dayton says a nine-month transition to a new Medicaid health care program carries "enormous financial implications" when state finances are already tight (12/20).

21 Dec 2010

Tips to find if a senior relative needs immediate medical attention

You're in from out of town and stop by to see Great Aunt Edna and Great Uncle Albert for the first time in a few years. But you become worried when you observe that the busy, meticulous couple of your youth is gone, replaced by a disheveled woman who won't get out of bed and a belligerent man who doesn't recognize you and thinks it is 1959.

21 Dec 2010

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Opsens Inc. today unveiled the EasyWire, developed by its medical division for the growth market of Fractional Flow Reserve for coronary lesion assessment.

20 Dec 2010

Chelsea completes successful NORTHERA pre-NDA assessment with FDA

Chelsea Therapeutics International, Ltd. announced it has completed a pre-NDA assessment with the U.S. Food and Drug Administration (FDA) and intends to accelerate its new drug application (NDA) for NORTHERA™(droxidopa) for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH), a chronic and potentially debilitating drop in blood pressure upon standing commonly associated Parkinson's disease, multiple system atrophy and pure autonomic failure.

20 Dec 2010

FDA moves to curb Avastin's approval for breast cancer

The Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicine helped patients with this disease, has drawn criticism from patients and politicians.

20 Dec 2010

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties - its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

20 Dec 2010

Best Buy announces national rollout of health, fitness products at 600 Best Buy stores

Today Best Buy announces the national rollout of health and fitness products at 600 Best Buy stores across the country and online at Bestbuy.com. The selection aims to satisfy consumers' health and fitness needs through an array of traditional and new connected offerings for holiday gifting and just in time for New Year health and fitness resolutions.

17 Dec 2010

Health inequalities still exist between England's richest and poorest

Significant health inequalities still exist between the country's richest and poorest according to the latest findings from the biggest annual survey of health in England, The Health Survey for England. The survey, conducted by the National Centre for Social Research and UCL and funded by The NHS Information Centre, shows that people in the lowest income households continue to experience much worse outcomes across key health measures than people in the highest income households.

17 Dec 2010